States ranked by 2015 generic drug savings

The U.S. saved $227 billion in 2015 through generic drug prescriptions, according to the 2016 Generic Drug Savings and Access in the United States report.

The report, created by QuintilesIMS Institute for the Generic Pharmaceutical Association, compares the total savings — including Medicare, Medicaid, commercial payer and uninsured cash saving — of all 50 states.

Here is a list of states ranked by total generic drug savings. Ties are represented with an asterisk.

1. California — $20.1 billion
2. New York — $19.2 billion
3. Texas — $16 billion
4. Florida — $13 billion
5. Pennsylvania — $10.5 billion
6. Ohio — $9.6 billion
7. Illinois — $8.9 billion
8. North Carolina — $7.5 billion
9. Michigan — $7.4 billion
10. Georgia — $7.2 billion
11. New Jersey — $6.1 billion
12. Tennessee — $6 billion
13. Virginia — $5.4 billion
14.Massachusetts — $5.2 billion
15. Indiana — $5 billion
16. Kentucky — $4.7 billion
     *Missouri — $4.7 billion
17. Alabama — $4.5 billion
18. Louisiana — $4.3 billion
19. Arizona — $4 billion
20. Washington — $3.8 billion
     *Wisconsin — $3.8 billion
21. Maryland — $3.7 billion
     *South Carolina — $3.7 billion
22. Minnesota — $3.3 billion
23. Arkansas — $2.8 billion
24. Mississippi — $2.7 billion
     *Oklahoma — $2.7 billion
25. Colorado — $2.6 billion
     *Connecticut — $2.6 billion
26. Iowa — $2.5 billion
27. Kansas — $2.3 billion
     *Oregon — $2.3 billion
28. West Virginia — $2.1 billion
29. Utah — $1.7 billion
30. Nevada — $1.6 billion
31. Nebraska — $1.5 billion
32. New Mexico — $1.1 billion
33. Rhode Island — $1 billion
34. Maine — $954 million
35. Idaho — $943 million
36. New Hampshire — $848 million
37. Hawaii — $721 million
38. Delaware — $659 million
39. North Dakota — $626 million
40. Montana — $602 million
41. South Dakota — $583 million
42. Vermont — $337 million
43. Wyoming — $312 million
44. Alaska — $294 million

More articles on supply chain:

4 latest FDA approvals
'Project Toto': CVS Health to open large distribution center in Kansas
FDA funds $23M in grants to spur rare disease drug research

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Learning Opportunities

Featured Whitepapers

Featured Webinars